Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 6, 2026
Researchers at Mount Sinai Hospital and School of Medicine have identified molecular "glues" that safeguard insulin-producing cells against damage related to diabetes. These molecular adhesins may hold promise for developing new treatments for the disease.
May 6, 2026
Researchers have discovered molecular glues that safeguard insulin-producing cells against damage associated with diabetes. These findings hold promise for developing new treatments to prevent or mitigate the progression of diabetes.
May 6, 2026
Researchers at Mount Sinai Hospital have discovered molecular compounds that can protect insulin-producing cells from damage related to diabetes. These "molecular glues" may hold promise for developing new treatments for the disease.
May 6, 2026
Researchers at the University of Kent have identified a skincare compound with the ability to effectively combat drug-resistant bacteria. This breakthrough discovery holds promise for the development of novel treatments for antibiotic-resistant infections.
May 6, 2026
University of Kent. "Scientists discover skincare compound that kills drug-resistant bacteria." ScienceDaily. ScienceDaily, 21 April 2026. <www.sciencedaily.com/releases/2026/04/260420014738.htm>...
May 6, 2026
Researchers at the University of Kent have identified a compound present in a common skincare ingredient that demonstrates potent antimicrobial activity against drug-resistant bacteria. This finding holds promise for the development of novel treatments to combat antibiotic-resistant infections.
May 6, 2026
Researchers have tested a topical cream that shows promise in reducing signs of aging. The product's efficacy has been evaluated in a scientific study, which sheds light on its potential as a therapeutic agent.
May 5, 2026
Scientists have identified a skincare compound that exhibits potent antimicrobial activity against drug-resistant bacteria. This breakthrough discovery may lead to the development of innovative treatments for skin infections caused by multidrug-resistant pathogens.
May 5, 2026
Researchers at the University of Kent have identified a skincare compound with potent antibacterial properties against drug-resistant bacteria. This breakthrough discovery holds promise for developing new treatments to combat antibiotic-resistant infections.
